Expert Opinion on Therapeutic Patents This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

PCSK9 inhibitors: a patent review 2018-2023
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 11, 2024 Category: Drugs & Pharmacology Authors: Enrico Mario Alessandro FassiAndrea CitarellaMarco AlbaniErica Ginevra MilanoLaura LegnaniCarmen LammiAlessandra SilvaniGiovanni Graziosoa Dipartimento di Scienze Farmaceutiche, Universit à degli Studi di Milano, Milano, Italyb Dipartimento di Chimica, U Source Type: research

A patent review on HMGB1 inhibitors for the treatment of liver diseases
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 9, 2024 Category: Drugs & Pharmacology Authors: Richa RajPingping ShenBoyang YuJian Zhanga Department of Resources Science of Traditional Chinese Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, P. R. Chinab Jiangsu Key Laboratory of TCM Evaluation and Transl Source Type: research

Targeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020 –2023)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 9, 2024 Category: Drugs & Pharmacology Authors: Dima A. SabbahRima HajjoSanaa K. BardaweelHaizhen A. Zhonga Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordanb Laboratory for Molecular Modeling, Division of Chemical Biology and Medicinal Chemistry, Eshelman Sc Source Type: research

An overview on recent patents and technologies on nanoparticles for nucleic acid delivery
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 8, 2024 Category: Drugs & Pharmacology Authors: Larissa Moraes dos Santos FonsecaBruna Aparecida Souza MachadoFabricia Oliveira OliveiraJ ânio Rodrigo de Jesus SantosJaqueline Wang da SilvaKatharine Valeria Saraiva HodelBrisa Gonçalves RosattiClaudio Damasceno PintoMilena Botelho Pereira Soaresa FIOC Source Type: research

Synthetic lethality: targeting SMARCA2 ATPase in SMARCA4-deficient tumors – a review of patent literature from 2019–30 June 2023
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 5, 2024 Category: Drugs & Pharmacology Authors: Kyle D. ReichlEsther C. Y. LeeAriamala GopalsamyOncology R & D, AstraZeneca, Waltham, MA, USA Source Type: research

Biofilm and bacterial membrane vesicles: recent advances
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 5, 2024 Category: Drugs & Pharmacology Authors: Valentina PucaBeatrice MarinacciBenedetta PellegriniFloriana CampanileMaria SantagatiRossella Grandea Department of Pharmacy, University “G. d’Annunzio” of Chieti-Pescara, Chieti, Italyb Department of Innovative Technologies in Medicine & Dentistry Source Type: research

Targeting the relaxin-3/RXFP3 system: a patent review for the last two decades
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 4, 2024 Category: Drugs & Pharmacology Authors: Md Toufiqur RahmanHetti Handi Chaminda LakmalJaveena HussainChunyang JinCenter for Drug Discovery, Research Triangle Institute, Research Triangle Park, NC, USA Source Type: research

Peroxisome Proliferator-Activated Receptor agonists and antagonists: an updated patent review (2020 –2023)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 21, 2024 Category: Drugs & Pharmacology Authors: Barbara De FilippisArianna GraneseAlessandra Ammazzalorsoa Department of Pharmacy, G. d ’Annunzio University, Chieti, Italyb Department of Drug Chemistry and Technology, “Sapienza” University of Rome, Rome, Italy Source Type: research

Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 20, 2024 Category: Drugs & Pharmacology Authors: Clemente CapassoClaudiu T. Supurana Department of Biology, Agriculture and Food Sciences, Institute of Biosciences and Bioresources, CNR, Napoli, Italyb NEUROFARBA Department, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, F Source Type: research

Therapeutic cysteine protease inhibitors: a patent review (2018 –present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 14, 2024 Category: Drugs & Pharmacology Authors: Giulia BarchielliAntonella CapperucciDamiano TaniniDepartment of Chemistry ‘Ugo Schiff’, University of Florence, Sesto Fiorentino FI, Italy Source Type: research

Targeting the EGFR/RAS/RAF signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020 –2023)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 13, 2024 Category: Drugs & Pharmacology Authors: Rima HajjoDima A. SabbahSanaa K. BardaweelHaizhen A. Zhonga Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordanb Laboratory for Molecular Modeling, Division of Chemical Biology and Medicinal Chemistry, Eshelman Sc Source Type: research

Successes and challenges in the development of BD1-selective BET inhibitors: a patent review
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 11, 2024 Category: Drugs & Pharmacology Authors: Monica VivianoAlessandra CiprianoEmanuele FabbriziAlessandra FeoliSabrina CastellanoGianluca SbardellaAntonello MaiCiro MiliteDante Rotilia Department of Pharmacy, Epigenetic Med Chem Lab, University of Salerno, Fisciano, SA, Italyb Department of Drug Che Source Type: research

Photodynamic therapy alone or in combination to counteract bacterial infections
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 11, 2024 Category: Drugs & Pharmacology Authors: S ébastien ClémentJean-Yves Winuma ICGM, University of Montpellier, CNRS, ENSCM, Montpellier, Franceb IBMM, University of Montpellier, CNRS, ENSCM, Montpellier, France Source Type: research

Recent developments of agents targeting Vibrio cholerae: patents and literature data
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 11, 2024 Category: Drugs & Pharmacology Authors: Francesco MelfiSimone CarradoriNoemi MencarelliCristina CampestreArianna GraneseMattia Moria Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italyb Department of Drug Chemistry and Technology, “Sapienza” University Source Type: research

Recent developments of HSP90 inhibitors: an updated patent review (2020-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 8, 2024 Category: Drugs & Pharmacology Authors: Jianfeng LiuHuangliang ShuQinxin XiaQidong YouLei Wanga State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, Chinab Department of Medicinal Chemistry, School of Pha Source Type: research